Kynurenines and Multiple Sclerosis: The Dialogue between the Immune System and the Central Nervous System (Q26796667)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26287161%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

2

Zsófia Majláth

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26287161%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

1

Cecilia Rajda

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26287161%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

author name string

Dániel Pukoli

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26287161%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Molecular Sciences

1 June 2020

language of work or name

English

0 references

publication date

6 August 2015

9 references

25 April 2019

30 June 2019

20 August 2019

12 September 2019

18 October 2019

19 November 2019

13 November 2020

25 January 2021

25 October 2022

10 references

25 April 2019

30 June 2019

20 August 2019

12 September 2019

18 October 2019

19 November 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26287161%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

13 November 2020

25 January 2021

25 October 2022

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26287161%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

18270-18282

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26287161%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26287161%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution

1 June 2020

copyright license

9 references

25 April 2019

30 June 2019

20 August 2019

12 September 2019

18 October 2019

19 November 2019

13 November 2020

25 January 2021

25 October 2022

0 references

on focus list of Wikimedia project

ScienceSource

0 references

cites work

Quinolinic acid selectively induces apoptosis of human astrocytes: potential role in AIDS dementia complex.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581244

Comparative inhibition by substrate analogues 3-methoxy- and 3-hydroxydesaminokynurenine and an improved 3 step purification of recombinant human kynureninase

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581244

Kynurenines in the mammalian brain: when physiology meets pathology

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581244

Structure, expression, and function of kynurenine aminotransferases in human and rodent brains

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581244

The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581244

Laquinimod, a quinoline-3-carboxamide, induces type II myeloid cells that modulate central nervous system autoimmunity

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581244

The immunopathology of multiple sclerosis: an overview

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581244

Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581244

Pathological mechanisms in progressive multiple sclerosis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581244

Quinolinic acid toxicity on oligodendroglial cells: relevance for multiple sclerosis and therapeutic strategies

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581244

Contribution of cortical lesion subtypes at 7T MRI to physical and cognitive performance in MS.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581244

Kynurenines in the CNS: recent advances and new questions.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581244

Placebo-controlled trial of oral laquinimod for multiple sclerosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581244

Quinolinic Acid, an endogenous molecule combining excitotoxicity, oxidative stress and other toxic mechanisms

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581244

Cinnabarinic acid, an endogenous metabolite of the kynurenine pathway, activates type 4 metabotropic glutamate receptors

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581244

Understanding the roles of the kynurenine pathway in multiple sclerosis progression.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581244

The kynurenine system and immunoregulation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581244

Oral laquinimod treatment in multiple sclerosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581244

Multiple sclerosis, seizures, and antiepileptics: role of IL-18, IDO, and melatonin.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581244

Endogenous neuroprotection in multiple sclerosis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581244

Immunosuppression routed via the kynurenine pathway: a biochemical and pathophysiologic approach.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581244

Characterization of the kynurenine pathway in human neurons

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581244

Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581244

Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581244

Treatment with laquinimod reduces development of active MRI lesions in relapsing MS.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581244

Expression of the kynurenine pathway enzymes in human microglia and macrophages

28 September 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581244

28 September 2017

https://api.crossref.org/works/10.3390%2FIJMS160818270

Kynurenic acid antagonists and kynurenine pathway inhibitors

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581244

Kynurenine 3-mono-oxygenase activity and neurotoxic kynurenine metabolites increase in the spinal cord of rats with experimental allergic encephalomyelitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581244

Tryptophan availability and the susceptibility to stress in multiple sclerosis: a hypothesis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581244

Neuropharmacology of quinolinic and kynurenic acids

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581244

Autoimmune diseases of myelin.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581244

Quantitative aspects of tryptophan metabolism in humans and other species: a review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581244

Plasma and cerebrospinal fluid tryptophan in multiple sclerosis and degenerative diseases

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581244

Decreased level of kynurenic acid in cerebrospinal fluid of relapsing-onset multiple sclerosis patients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581244

Direct evidence that release-stimulating alpha7* nicotinic cholinergic receptors are localized on human and rat brain glutamatergic axon terminals

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581244

IFN-beta1b induces kynurenine pathway metabolism in human macrophages: potential implications for multiple sclerosis treatment

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581244

Quinolinic acid production by macrophages stimulated with IFN-gamma, TNF-alpha, and IFN-alpha.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581244

A glycine site associated with N-methyl-D-aspartic acid receptors: characterization and identification of a new class of antagonists

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581244

Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions.

31 May 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS160818270

Kynurenic acid has a dual action on AMPA receptor responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS160818270

The Janus-face kynurenic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS160818270

Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS160818270

T cell apoptosis by tryptophan catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS160818270

Indolamine 2,3-dioxygenase is expressed in the CNS and down-regulates autoimmune inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS160818270

Oligodendrocyte killing by quinolinic acid in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS160818270

Chronic exposure of human neurons to quinolinic acid results in neuronal changes consistent with AIDS dementia complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS160818270

Acute intrastriatal administration of quinolinic acid provokes hyperphosphorylation of cytoskeletal intermediate filament proteins in astrocytes and neurons of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS160818270

Oxidative modification of blood serum proteins in multiple sclerosis after interferon or mitoxantrone treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS160818270

Quinolinic acid is produced by macrophages stimulated by platelet activating factor, Nef and Tat.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS160818270

Kynurenine metabolism in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS160818270

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS160818270

Astrocytic activation in relation to inflammatory markers during clinical exacerbation of relapsing-remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS160818270

Modulation of blood-brain barrier dysfunction and neurological deficits during acute experimental allergic encephalomyelitis by the N-methyl-D-aspartate receptor antagonist memantine

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS160818270

The mechanism of inactivation of 3-hydroxyanthranilate-3,4-dioxygenase by 4-chloro-3-hydroxyanthranilate

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS160818270

Laquinimod suppress antigen presentation in relapsing-remitting multiple sclerosis: in-vitro high-throughput gene expression study

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS160818270

Suppression of experimental autoimmune neuritis by ABR-215062 is associated with altered Th1/Th2 balance and inhibited migration of inflammatory cells into the peripheral nerve tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS160818270

Laquinimod interferes with migratory capacity of T cells and reduces IL-17 levels, inflammatory demyelination and acute axonal damage in mice with experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS160818270

Oral treatment with laquinimod augments regulatory T-cells and brain-derived neurotrophic factor expression and reduces injury in the CNS of mice with experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS160818270

Type II monocytes modulate T cell-mediated central nervous system autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS160818270

Metabotropic glutamate receptor-4 modulates adaptive immunity and restrains neuroinflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS160818270

Cinnabarinic acid, an endogenous agonist of type-4 metabotropic glutamate receptor, suppresses experimental autoimmune encephalomyelitis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS160818270

Immunosuppression via tryptophan catabolism: the role of kynurenine pathway enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS160818270

Insight into the mechanism of laquinimod action

21 January 2018

1 reference

12 December 2020

Abnormally phosphorylated tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosis

1 reference

12 December 2020

Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations?

1 reference

12 December 2020

Serum tryptophan, kynurenine, and neopterin in patients with Guillain-Barre-syndrome (GBS) and multiple sclerosis (MS)

1 reference

12 December 2020

Neurotoxin quinolinic acid is selectively elevated in spinal cords of rats with experimental allergic encephalomyelitis

1 reference

12 December 2020

Comparison of the neurochemical and behavioral effects resulting from the inhibition of kynurenine hydroxylase and/or kynureninase

1 reference

12 December 2020

Identifiers

DOI

10.3390/IJMS160818270

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26287161%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

1 reference

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26287161%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26287161%20AND%20SRC:MED&resulttype=core&format=json